Analyst firms · Raymond James · CDNA

Raymond James CDNA price target and rating history

CareDx Inc. (CDNA) · Health Care

Raymond James rates CareDx Inc. (CDNA) Mkt Perform with a $12 price target, as of its latest action on May 13, 2024. It has published 6 rating actions on CDNA since June 2021, including 1 upgrade and 2 downgrades. Across 3 firms with a CDNA price target in the last 12 months, the median target is $65.

Current rating
Mkt Perform
Price target
$12
Median target, all firms
$65
Actions on CDNA
6

Raymond James price target on CDNA

$108$60$1220222023202420252026
Raymond James price target on CDNA, each point a stated target, June 2021 to August 2023.

Every Raymond James rating on CDNA

How other firms rate CDNA

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerOverweight$100Nov 11, 2026
Canaccord GenuityBuy$65Sep 2, 2026
Craig-HallumBuy$64Aug 3, 2026

Questions about Raymond James and CDNA

What is Raymond James's price target for CDNA?
Raymond James's latest stated price target for CareDx Inc. (CDNA) is $12, from its action on Aug 15, 2023.
What is Raymond James's rating on CDNA?
Raymond James rates CDNA Mkt Perform, a neutral rating, as of May 13, 2024.
When did Raymond James last change its view on CDNA?
On May 13, 2024, Raymond James downgrades to Mkt Perform from Outperform.
How does Raymond James's CDNA target compare with other analysts?
Across 3 firms with a CDNA price target in the last 12 months, the median target is $65.

More CDNA rating histories

All Raymond James ratingsCDNA news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.